// App-Quantinova.ai

2403 : Molecular mechanisms orchestrating intratumoral heterogeneity in Kras-driven carcinomas

Researchers

Presenter

  • Roxana Azimi

Principal Investigators

  • N/A

Medical Centers

  • Massachusetts Institute of Technology, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Advanced refractory tumors

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved